JOURNAL OF IMMUNOLOGY

Scope & Guideline

Connecting Researchers for a Healthier Tomorrow

Introduction

Explore the comprehensive scope of JOURNAL OF IMMUNOLOGY through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore JOURNAL OF IMMUNOLOGY in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0022-1767
PublisherAMER ASSOC IMMUNOLOGISTS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1945 to 2024
AbbreviationJ IMMUNOL / J. Immunol.
Frequency24 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address9650 ROCKVILLE PIKE, BETHESDA, MD 20814

Aims and Scopes

The Journal of Immunology focuses on advancing the understanding of the immune system through innovative research and clinical studies. It encompasses a broad spectrum of immunological topics, from basic research to clinical applications, with an emphasis on the mechanisms of immune response, disease pathogenesis, and therapeutic interventions.
  1. Basic Immunology Research:
    The journal publishes studies that explore fundamental aspects of the immune system, including cellular and molecular mechanisms, signaling pathways, and immune cell functions.
  2. Clinical Immunology and Therapeutics:
    Research related to the clinical implications of immunology, including the development of immunotherapies for various diseases, vaccine research, and the role of the immune system in disease progression and treatment.
  3. Autoimmunity and Inflammation:
    Studies focusing on autoimmunity, chronic inflammation, and their underlying mechanisms, as well as the identification of novel therapeutic targets for autoimmune diseases.
  4. Infectious Diseases and Immunity:
    Research addressing the immune response to infectious agents, vaccine efficacy, and the immunopathogenesis of infectious diseases.
  5. Cancer Immunology:
    Exploration of the immune system's role in cancer biology, including mechanisms of tumor immune evasion, immunotherapy strategies, and the influence of the tumor microenvironment on immune responses.
  6. Translational Immunology:
    Research that bridges basic immunology and clinical applications, promoting the translation of laboratory findings into therapeutic strategies for immunological diseases.
Recent publications in the Journal of Immunology indicate a shift towards several trending and emerging themes. These themes reflect the current priorities in immunological research and the ongoing response to global health challenges.
  1. COVID-19 Immunology:
    Research focusing on the immune response to SARS-CoV-2, including vaccine efficacy, long-term immunity, and the role of specific immune cells in disease outcomes, is increasingly prevalent, driven by the global pandemic.
  2. Biomarkers in Immunology:
    There is a growing emphasis on identifying and validating biomarkers for diagnosing and monitoring autoimmune diseases, cancer, and infections, which can aid in personalized medicine approaches.
  3. Microbiome and Immune Interactions:
    Studies exploring the relationship between the microbiome and immune system function are gaining traction, highlighting how gut health influences systemic immunity and disease susceptibility.
  4. Immunotherapy Advancements:
    Research on novel immunotherapeutic strategies, including CAR T-cell therapy and immune checkpoint inhibitors, is on the rise, reflecting the ongoing revolution in cancer treatment and autoimmune disease management.
  5. Inflammatory Pathways and Disease Mechanisms:
    Investigations into specific inflammatory pathways, such as the NF-κB signaling cascade, and their roles in various diseases are increasingly common, underscoring the importance of inflammation in health and disease.

Declining or Waning

While the Journal of Immunology continues to thrive in various areas, certain themes have shown a decline in publication frequency. This reflects shifts in research focus and funding availability, as well as the evolving landscape of immunological studies.
  1. Traditional Vaccines Research:
    Research on traditional vaccine development has seen a waning focus, as attention shifts towards novel vaccine platforms, such as mRNA vaccines and personalized immunotherapies, particularly in the context of emerging infectious diseases.
  2. Infectious Disease Mechanisms:
    While still important, studies solely focused on the mechanistic understanding of infectious diseases have become less prominent compared to research that integrates immunological insights with therapeutic applications.
  3. Basic Research on Non-Human Models:
    The reliance on non-human models in immunological research appears to be decreasing, as there is a growing emphasis on human-derived data and translational studies that directly inform clinical practices.
  4. Historical Perspectives on Immunology:
    Papers providing historical overviews or theoretical discussions about immunology are becoming less common, as the journal increasingly prioritizes cutting-edge experimental and clinical research.

Similar Journals

JOURNAL OF EXPERIMENTAL MEDICINE

Innovating Solutions for Tomorrow's Health Challenges
Publisher: ROCKEFELLER UNIV PRESSISSN: 0022-1007Frequency: 12 issues/year

JOURNAL OF EXPERIMENTAL MEDICINE, published by Rockefeller University Press, is a renowned peer-reviewed journal dedicated to advancing the field of experimental medicine since its inception in 1896. With an impressive impact factor and categorized in the Q1 quartile for Immunology, Immunology and Allergy, and Miscellaneous Medicine, this journal stands at the forefront of medical research and innovation. It provides a prestigious platform for scholars and practitioners to disseminate groundbreaking findings that drive the understanding of disease mechanisms and therapeutic strategies. While the journal is not open access, it maintains high visibility and engagement within the scientific community, fostering collaboration among researchers, professionals, and students alike. The journal's consistent ranking in the top percentiles of Scopus illustrates its significant impact and commitment to excellence in medical research.

NATURE IMMUNOLOGY

Pioneering insights that shape the future of immunology.
Publisher: NATURE PORTFOLIOISSN: 1529-2908Frequency: 12 issues/year

NATURE IMMUNOLOGY is a premier academic journal published by NATURE PORTFOLIO, dedicated to advancing the field of immunology. With an impressive impact factor that reflects its esteemed position, this journal ranks in the top quartile (Q1) of renowned categories, including Immunology and Allergy. Serving as a crucial platform for researchers, professionals, and students, NATURE IMMUNOLOGY showcases cutting-edge research, comprehensive reviews, and insightful perspectives that drive innovation in immunological science. Based in the United Kingdom, this journal has been a vital contributor to the global discourse on immune responses and related diseases since its inception in 2000. Researchers can benefit from its rigorous peer-review process, ensuring that only high-quality studies are disseminated, thus enhancing their academic pursuits and practical applications. Explore the latest findings and trends within this flourishing discipline, making NATURE IMMUNOLOGY an essential resource for anyone engaged in the study of the immune system.

GENES AND IMMUNITY

Advancing the Frontiers of Genetics and Immunology
Publisher: SPRINGERNATUREISSN: 1466-4879Frequency: 8 issues/year

GENES AND IMMUNITY, published by SpringerNature, is a leading scholarly journal dedicated to advancing the field of genetics and immunology. With an impressive impact factor and a distinguished ranking in the Q1 quartile of both Genetics and Immunology disciplines for 2023, this journal serves as a pivotal platform for researchers and professionals looking to explore the intricate relationships between genetic factors and immune responses. Established in 1999 and continuously published until 2024, it features high-quality peer-reviewed research articles, reviews, and commentary that address critical issues and recent advancements in the field. The journal adheres to rigorous academic standards, evidenced by its strong Scopus rankings, making it a valuable resource for students, researchers, and practitioners alike who are seeking to deepen their understanding of genetics' role in immunity. For those looking to keep abreast of cutting-edge insights, GENES AND IMMUNITY is an essential read.

VIRAL IMMUNOLOGY

Advancing knowledge at the intersection of virus and immunity.
Publisher: MARY ANN LIEBERT, INCISSN: 0882-8245Frequency: 10 issues/year

Viral Immunology, published by Mary Ann Liebert, Inc, stands as a prominent journal dedicated to advancing the understanding of the interplay between viral infections and host immune responses. With a strong focus on immunology, molecular medicine, and virology, the journal provides a platform for the dissemination of high-quality research findings and innovative methodologies that could shape the future of these critical fields. Although it currently holds a Q3 rating across its relevant categories and a respectable ranking within the Scopus database, Viral Immunology continues to strive for excellence with a commitment to publishing influential research that informs both academic and clinical practices. The journal accepts submissions in various formats—original research, reviews, and commentaries—catering to a diverse readership that includes researchers, professionals, and students engaged in the biological and medical sciences. Readers can anticipate insightful articles that address urgent challenges in immunological responses to viral infections, paving the way for new therapeutic strategies and public health initiatives.

Immuno

Advancing Immunology Through Open Access Innovation
Publisher: MDPIISSN: Frequency: 4 issues/year

Welcome to Immuno, a pioneering open-access journal published by MDPI that serves as a key platform for the dissemination of innovative research in the fields of immunology, biochemistry, and genetics. Established in 2021, this journal has rapidly established itself within the academic community, currently ranking in the 53rd percentile in Medicine (miscellaneous) and 50th percentile in Biochemistry, Genetics, and Molecular Biology according to Scopus metrics. With a commitment to advancing our understanding of immune mechanisms and their applications in health and disease, Immuno is dedicated to publishing high-quality peer-reviewed articles that contribute valuable insights to both researchers and practitioners. Positioned in the heart of Switzerland, its global accessibility and diverse editorial board are a testament to its aim to promote knowledge exchange among scientists, practitioners, and students alike. Explore the latest discoveries and advancements in immunological research through Immuno, where your contributions help shape the future of this critical area of study.

TRENDS IN IMMUNOLOGY

Shaping the Future of Immunology Through Comprehensive Reviews
Publisher: CELL PRESSISSN: 1471-4906Frequency: 12 issues/year

TRENDS IN IMMUNOLOGY, published by CELL PRESS, stands as a premier source of insights and developments within the field of immunology. With an ISSN of 1471-4906 and E-ISSN of 1471-4981, this journal has established a strong reputation, evidenced by its prestigious status in Q1 quartiles for both Immunology and Allergy in 2023. It is ranked #13 out of 233 in the Scopus category of Medicine – Immunology and Allergy, and #16 out of 236 in Immunology and Microbiology, placing it within the top 94th and 93rd percentiles respectively. Since its inception in 1987, TRENDS IN IMMUNOLOGY has provided a critical platform for researchers, professionals, and students to access the latest advancements and integrative reviews in immunological research. The journal offers open access options, enhancing the accessibility of its high-impact content to a global audience. Researchers and practitioners rely on its pages not only for cutting-edge findings but also for comprehensive discussions that drive the future of immunology research.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Unveiling Breakthroughs in Experimental Immunology
Publisher: OXFORD UNIV PRESSISSN: 0009-9104Frequency: 12 issues/year

Clinical and Experimental Immunology, published by Oxford University Press, is a premier journal that has been a cornerstone in the field of immunology since its inception in 1966. With an ISSN of 0009-9104 and an E-ISSN of 1365-2249, this journal holds a significant position in academic research, currently ranking in the Q2 category for both Immunology and Allergy (2023). Its impactful contributions are reflected in its Scopus rankings, where it stands at Rank #63 out of 233 in Immunology and Allergy, placing it in the 73rd percentile, and Rank #73 out of 236 in Immunology and Microbiology. Researchers, healthcare professionals, and students will find this journal an invaluable resource for cutting-edge studies, reviews, and clinical advancements in the ever-evolving domain of immunology. While the publication does not offer open-access options, it remains a pivotal platform for disseminating knowledge that impacts both clinical practice and experimental research.

IMMUNOLOGY

Connecting Basic Science with Clinical Applications
Publisher: WILEYISSN: 0019-2805Frequency: 12 issues/year

IMMUNOLOGY is a premier journal published by Wiley that has been at the forefront of the field since its inception in 1958. With an impressive impact factor and classified in the Q1 quartile for both Immunology and Allergy as of 2023, this journal is highly regarded among researchers and professionals alike. It ranks 36th out of 233 in the Medicine/Immunology and Allergy category, and 40th out of 236 in the Immunology and Microbiology segment on Scopus, placing it firmly within the top percentile of its field. The journal is dedicated to publishing high-quality research that advances our understanding of immunological processes, bridging basic science with clinical applications. Although it does not operate under an open-access model, it offers conventional access options that remain integral to the dissemination of vital immunological research. With its broad scope and commitment to scholarly excellence, IMMUNOLOGY continues to serve as an essential resource for those seeking the latest advancements in immunology, fostering innovation and collaboration among scientists globally.

CRITICAL REVIEWS IN IMMUNOLOGY

Advancing the Frontiers of Immune Science
Publisher: BEGELL HOUSE INCISSN: 1040-8401Frequency: 6 issues/year

CRITICAL REVIEWS IN IMMUNOLOGY, published by BEGELL HOUSE INC, is an essential journal in the field of immunology that has been contributing to the scientific discourse since 1980. With its ISSN 1040-8401 and E-ISSN 2162-6472, this journal provides a platform for critical analysis and comprehensive reviews that deepen understanding of immune responses and their implications in health and disease. Although currently categorized in the Q4 quartile for Immunology and Q3 for Immunology and Allergy, the journal's quality research and scholarly contributions are crucial for advancing knowledge within its fields—encompassing various aspects of innate and adaptive immunity. Researchers and professionals in immunology will find invaluable insights, aiding them in their quest for innovation and excellence, as the journal aims to foster interdisciplinary collaboration. While it does not operate on an open-access model, CRITICAL REVIEWS IN IMMUNOLOGY remains a significant resource for those dedicated to pushing the boundaries of immunology, with annual publications expected to last well into 2024 and beyond.

BMC IMMUNOLOGY

Unlocking the Mysteries of the Immune System
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Immunology is a prominent open-access journal published by BMC that has been at the forefront of immunological research since its inception in 2000. Based in the United Kingdom, this journal aims to advance the understanding of immune system functions and disorders through high-quality, peer-reviewed articles. With an impressive scope encompassing various facets of immunology, BMC Immunology has earned a Q3 ranking in the Immunology category according to the 2023 category quartiles, demonstrating its growing impact and relevance in the scientific community. Researchers and professionals will find valuable insights in its array of published works, spanning both foundational studies and innovative applications. The journal's commitment to open access ensures that cutting-edge research is freely available, fostering collaboration and advancement in the field. For those looking to stay updated on the latest developments in immunology, BMC Immunology stands as an essential resource for researchers, professionals, and students alike.